ZA927747B - Novel 17 beta-substituted aza-androstane derivatives - Google Patents

Novel 17 beta-substituted aza-androstane derivatives

Info

Publication number
ZA927747B
ZA927747B ZA927747A ZA927747A ZA927747B ZA 927747 B ZA927747 B ZA 927747B ZA 927747 A ZA927747 A ZA 927747A ZA 927747 A ZA927747 A ZA 927747A ZA 927747 B ZA927747 B ZA 927747B
Authority
ZA
South Africa
Prior art keywords
phe
formula
group
beta
novel
Prior art date
Application number
ZA927747A
Other languages
English (en)
Inventor
Michel Biollaz
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of ZA927747B publication Critical patent/ZA927747B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA927747A 1991-10-09 1992-10-08 Novel 17 beta-substituted aza-androstane derivatives ZA927747B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH297891 1991-10-09

Publications (1)

Publication Number Publication Date
ZA927747B true ZA927747B (en) 1993-04-13

Family

ID=4245915

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA927747A ZA927747B (en) 1991-10-09 1992-10-08 Novel 17 beta-substituted aza-androstane derivatives

Country Status (19)

Country Link
US (2) US5304562A (fi)
EP (1) EP0538192B1 (fi)
JP (1) JPH05213989A (fi)
KR (1) KR930007969A (fi)
AT (1) ATE152121T1 (fi)
AU (1) AU657579B2 (fi)
CA (1) CA2080054A1 (fi)
DE (1) DE59208383D1 (fi)
DK (1) DK0538192T3 (fi)
ES (1) ES2101073T3 (fi)
FI (1) FI924529A (fi)
GR (1) GR3024013T3 (fi)
HU (1) HUT62600A (fi)
IL (1) IL103361A (fi)
MX (1) MX9205792A (fi)
NO (1) NO923911L (fi)
NZ (1) NZ244640A (fi)
TW (1) TW263513B (fi)
ZA (1) ZA927747B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304562A (en) * 1991-10-09 1994-04-19 Ciba-Geigy Corporation 17β-substituted Aza-androstane derivatives
WO1993023419A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. NEW 7β-SUBSTITUTED-4-AZA-5α-CHOLESTAN-ONES AS 5α-REDUCTASE INHIBITORS
WO1993023039A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. Substituted 4-aza-5a-androstan-ones as 5a-reductase inhibitors
GB9210880D0 (en) * 1992-05-21 1992-07-08 Smithkline Beecham Corp Compounds
GB9216284D0 (en) * 1992-07-31 1992-09-16 Erba Carlo Spa Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives
HU212459B (en) * 1992-10-02 1996-06-28 Richter Gedeon Vegyeszet Process for producing new 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them
AU5323694A (en) * 1992-10-06 1994-04-26 Merck & Co., Inc. 17beta -carboxanilides of 4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
US5470976A (en) * 1994-09-07 1995-11-28 Merck & Co., Inc. Process for the stereoselective reduction of steroid enelactams
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
US5595996A (en) * 1994-10-25 1997-01-21 Merck & Co., Inc. 7-substituted 4-aza cholanic acid derivatives and their use
US5656613A (en) * 1995-01-04 1997-08-12 Merck & Co., Inc. Treatment of hyperandrogenic conditions
US6001844A (en) * 1995-09-15 1999-12-14 Merck & Co., Inc. 4-Azasteroids for treatment of hyperandrogenic conditions
WO1997010217A1 (en) * 1995-09-15 1997-03-20 Merck & Co., Inc. 4-azasteroids for treatment of hyperandrogenic conditions
US5998427A (en) * 1998-05-14 1999-12-07 Glaxo Wellcome Inc. Androstenones
US6645974B2 (en) 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US5049562A (en) * 1984-02-27 1991-09-17 Merck & Co., Inc. 17β-acyl-4-aza-5α-androst-1-ene-3-ones as 5α-reductase inhibitors
NZ211145A (en) * 1984-02-27 1988-10-28 Merck & Co Inc 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
GB8505862D0 (en) * 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
US4845104A (en) * 1986-11-20 1989-07-04 Merck & Co., Inc. Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones
EP0271219B1 (en) * 1986-11-20 1992-07-29 Merck & Co. Inc. Topical pharmaceutical composition containing 17-beta-methoxycarbonyl-4-methyl-4-aza-5-alpha-androst-1-en-3-one
US4888336A (en) * 1987-01-28 1989-12-19 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
EP0285383B1 (en) * 1987-04-03 1994-03-16 Merck & Co. Inc. Treatment of prostatic carcinoma with 17beta-n-monosubstituted-carbamoyl-4-aza-5alpha-androst-1-en-3-ones
US5237061A (en) * 1988-10-31 1993-08-17 Merck & Co., Inc. Methods of synthesizing benign prostatic hypertropic agents and their intermediates
ATE170753T1 (de) * 1989-07-07 1998-09-15 Endorecherche Inc Androgenderivate zur hemming der aktivität der sexualsteroide
CA2023157A1 (en) * 1989-08-21 1991-02-22 Gary H. Rasmusson 17 beta-acyl-4-aza-5 alpha-androst-1-ene-3-ones as 5 alpha-reductase inhibitors
US5120847A (en) * 1990-08-27 1992-06-09 Merck & Co., Inc. Process for iodinating or brominating the α-methylenic carbon of a secondary amide
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
US5304562A (en) * 1991-10-09 1994-04-19 Ciba-Geigy Corporation 17β-substituted Aza-androstane derivatives

Also Published As

Publication number Publication date
GR3024013T3 (en) 1997-10-31
CA2080054A1 (en) 1993-04-10
ES2101073T3 (es) 1997-07-01
US5378710A (en) 1995-01-03
AU2626192A (en) 1993-04-22
EP0538192A1 (de) 1993-04-21
DE59208383D1 (de) 1997-05-28
NO923911D0 (no) 1992-10-08
JPH05213989A (ja) 1993-08-24
EP0538192B1 (de) 1997-04-23
MX9205792A (es) 1993-08-01
IL103361A (en) 1997-06-10
HUT62600A (en) 1993-05-28
TW263513B (fi) 1995-11-21
HU9203189D0 (en) 1992-12-28
AU657579B2 (en) 1995-03-16
FI924529A0 (fi) 1992-10-07
NO923911L (no) 1993-04-13
ATE152121T1 (de) 1997-05-15
DK0538192T3 (da) 1997-05-20
IL103361A0 (en) 1993-03-15
US5304562A (en) 1994-04-19
NZ244640A (en) 1994-12-22
KR930007969A (ko) 1993-05-20
FI924529A (fi) 1993-04-10

Similar Documents

Publication Publication Date Title
ZA927747B (en) Novel 17 beta-substituted aza-androstane derivatives
DE3789967D1 (de) Anwendung von monoaminakridinen bei mangelerscheinungen des cholinergen nervensystems.
BG104853A (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
EP0324387A3 (en) Composition for treatment of ischemic disorder in organs
ATE121744T1 (de) Neue triazolopyrimidin- und pyrazolopyrimidinderivate zur behandlung von kachexie.
AU3381389A (en) Derivative of caffeic acid and pharmaceutical composition containing the same
AU713526C (en) 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation
MY108849A (en) Novel compound
AU576887B2 (en) 1,6-naphthyridine derivatives
ZA928395B (en) Butyric acid derivatives.
HU906230D0 (en) Process for the preparation of benzanilide derivatives and medical preparations containing them
SE7412163L (fi)
AU591255B2 (en) New derivatives of 1-styrenesulphonyl-2-oxo-5-hydroxy pyrrolidine, the process and the intermediates for their preparations, their application as medicaments and the compositions containing them
MXPA01005363A (es) 4'-substituido-4',5'-dihidropsoralen y usos terapeuticos del mismo.
ES8507560A1 (es) Procedimiento para preparar derivados del acido acrilico